These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26853144)

  • 1. Stroke in Young-Dilative Arteriopathy: A Clue to Late-Onset Pompe's Disease?
    Huded V; Bohra V; Prajapati J; DeSouza R; Ramankutty R
    J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):e50-2. PubMed ID: 26853144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A retrospective study of six patients with late-onset Pompe disease].
    Saux A; Laforet P; Pagès AM; Figarella-Branger D; Pellissier JF; Pagès M; Labauge P
    Rev Neurol (Paris); 2008 Apr; 164(4):336-42. PubMed ID: 18439925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dilative arteriopathy in metabolic myopathies, particularly Pompe's disease.
    Finsterer J
    Acta Neurol Belg; 2012 Mar; 112(1):15-8. PubMed ID: 22427284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse cerebral microhemorrhages in a patient with adult-onset Pompe's disease: a case report.
    Sandhu D; Rizvi A; Kim J; Reshi R
    J Vasc Interv Neurol; 2014 Dec; 7(5):82-5. PubMed ID: 25566347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-onset Pompe's disease.
    Teener JW
    Semin Neurol; 2012 Nov; 32(5):506-11. PubMed ID: 23677658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enzyme replacement therapy in Pompe's disease].
    Merk T; Wibmer T; Schumann C; Krüger S
    Med Klin (Munich); 2007 Jul; 102(7):570-3. PubMed ID: 17634875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restrictive Arteriopathy in Late-Onset Pompe Disease: Case Report and Review of the Literature.
    Malhotra K; Carrington DC; Liebeskind DS
    J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):e172-e175. PubMed ID: 28647415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late-onset Pompe's disease in a hemodialysis patient: A first case report.
    Eleftheriadis T; Makri P; Karakosta P; Pissas G; Liakopoulos V; Michelakakis H; Hadjigeorgiou GM; Stefanidis I
    Hemodial Int; 2018 Apr; 22(2):E23-E25. PubMed ID: 28972689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late Onset Pompe's Disease: Clinical, Pathological & Molecular Analysis of Two Adolescent Patients.
    Parameswaran AS; Singh ; Saini L; Aggarwal D
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up.
    Winkel LP; Van den Hout JM; Kamphoven JH; Disseldorp JA; Remmerswaal M; Arts WF; Loonen MC; Vulto AG; Van Doorn PA; De Jong G; Hop W; Smit GP; Shapira SK; Boer MA; van Diggelen OP; Reuser AJ; Van der Ploeg AT
    Ann Neurol; 2004 Apr; 55(4):495-502. PubMed ID: 15048888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients.
    Hagemans ML; Winkel LP; Van Doorn PA; Hop WJ; Loonen MC; Reuser AJ; Van der Ploeg AT
    Brain; 2005 Mar; 128(Pt 3):671-7. PubMed ID: 15659425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal tongue features as a clinical clue for late-onset Pompe's disease.
    Pinto WBVR; Souza PVS; Bortholin T; Naylor FGM; Oliveira ASB
    Arq Neuropsiquiatr; 2017 Nov; 75(11):835-836. PubMed ID: 29236832
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for later-onset Pompe's disease in patients with paucisymptomatic hyperCKemia.
    Spada M; Porta F; Vercelli L; Pagliardini V; Chiadò-Piat L; Boffi P; Pagliardini S; Remiche G; Ronchi D; Comi G; Mongini T
    Mol Genet Metab; 2013 Jun; 109(2):171-3. PubMed ID: 23566438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural course of non-classic Pompe's disease; a review of 225 published cases.
    Winkel LP; Hagemans ML; van Doorn PA; Loonen MC; Hop WJ; Reuser AJ; van der Ploeg AT
    J Neurol; 2005 Aug; 252(8):875-84. PubMed ID: 16133732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical manifestations, course and outcome of enzyme replacement therapy in Hungarian patients with Pompe's disease].
    Bereznai B; Trauninger A; György I; Szakszon K; Almássy Z; Pál E; Herczegfalvi A; Várdi Visy K; Illés Z; Molnár MJ
    Orv Hetil; 2011 Sep; 152(39):1569-75. PubMed ID: 21920843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized study of alglucosidase alfa in late-onset Pompe's disease.
    van der Ploeg AT; Clemens PR; Corzo D; Escolar DM; Florence J; Groeneveld GJ; Herson S; Kishnani PS; Laforet P; Lake SL; Lange DJ; Leshner RT; Mayhew JE; Morgan C; Nozaki K; Park DJ; Pestronk A; Rosenbloom B; Skrinar A; van Capelle CI; van der Beek NA; Wasserstein M; Zivkovic SA
    N Engl J Med; 2010 Apr; 362(15):1396-406. PubMed ID: 20393176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pompe's disease. Part I: pathogenesis and clinical features].
    Illés Z; Trauninger A
    Ideggyogy Sz; 2009 Jul; 62(7-8):231-43. PubMed ID: 19685701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pompe's disease.
    van der Ploeg AT; Reuser AJ
    Lancet; 2008 Oct; 372(9646):1342-53. PubMed ID: 18929906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hearing loss in infantile Pompe's disease and determination of underlying pathology in the knockout mouse.
    Kamphoven JH; de Ruiter MM; Winkel LP; Van den Hout HM; Bijman J; De Zeeuw CI; Hoeve HL; Van Zanten BA; Van der Ploeg AT; Reuser AJ
    Neurobiol Dis; 2004 Jun; 16(1):14-20. PubMed ID: 15207257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A severe form of non-classic Pompe's disease with normal creatinine kinase level.
    Demirkol D; Caliskan M; Gökcay G; Yanni D; Citak A; Oflazer PS; Karaböcüoğlu M
    Neuropediatrics; 2010 Aug; 41(4):193-5. PubMed ID: 21086226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.